Nyumbani › Mfumo wa Kinga na Magonjwa › Nebraska › Omaha
Majaribio ya kliniki ya Mfumo wa Kinga na Magonjwa katika Omaha, NE
Masomo 3 ya Mfumo wa Kinga na Magonjwa yanatafuta washiriki katika vituo vya Omaha na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
InaajiriUtafiti wa uchunguzi
- Nebraska Medicine-Village Pointe, Omaha
- University of Nebraska Medical Center, Omaha
- Nebraska Medicine-Bellevue, Bellevue · Mi 9 mbali
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
InaajiriHatua 1/2
- University of Nebraska Medical Center, Omaha
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
InaajiriHatua 1/2
- Fred and Pamela Buffett Cancer Center, Omaha
Majaribio ya Mfumo wa Kinga na Magonjwa katika miji mingine
- Washington, DCUtafiti 13
- New York City, NYUtafiti 12
- Boston, MAUtafiti 10
- Philadelphia, PAUtafiti 10
- Portland, ORUtafiti 9
- Atlanta, GAUtafiti 9
- Houston, TXUtafiti 9
- Cleveland, OHUtafiti 8
- Chicago, ILUtafiti 8
- Los Angeles, CAUtafiti 8
- Milwaukee, WIUtafiti 6
- Seattle, WAUtafiti 6
Masomo mengine katika Omaha
- Saratani ya ProstateUtafiti 27
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 24
- Saratani ya MatitiUtafiti 22
- Kansari ya kolorektaliUtafiti 18
- Saratani (aina zote)Utafiti 18
- Multiple MyelomaUtafiti 16
- Limfoma ya Non-HodgkinUtafiti 14
- Kansari ya MayaiUtafiti 14
- Kansari ya PancreasUtafiti 14
- Kansari ya Seluli za Skwamu za Kichwa na ShingoUtafiti 13
- Kushindwa kwa MoyoUtafiti 13
- Saratani ya MetastasiUtafiti 13
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.